Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia by Fabron Junior, Antonio et al.
38
Antonio Fabron Junior
Gilberto Moreira Junior
José Orlando Bordin
Case Report
REVISTA PAULISTA DE MEDICINA
Medical JournalS ã o  P a u l o
INTRODUCTION
Red blood cell (RBC) transfusions are widely
used in the management of patients with sickle
cell anemia (SCA). We reported recently that the
calculated risk of RBC alloimmunization per
transfused unit in Brazilian patients with SCA is
lower than that reported by studies from North
America (1.15 vs. 3.10%), reflecting a more
concordant RBC phenotype between blood donors
and recipients in Brazil.
1,2
 Therefore, we have not
been routinely performing extended RBC
phenotyping on all SCA patients prior to initiating
a transfusion program. Nevertheless, in the present
report we describe the occurrence of a delayed
hemolytic transfusion reaction (DHTR) presenting
as a painful crisis in a patient with SCA in Brazil.
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Figure 1 - Delayed hemolytic transfusion reaction
presenting as a sickle cell crisis in a Brazilian patient
with sickle cell anemia. The arrows indicate the
packed RBC units transfused.
ABSTRACT
Context: Patients with sickle cell anemia (SCA) are
frequently transfused with red blood cells (RBC). Recently,
we reported that the calculated risk of RBC
alloimmunization per transfused unit in Brazilian patients
with SCA is 1.15%. We describe a delayed hemolytic
transfusion reaction (DHTR) presenting as a painful crisis in
a patient with SCA.
Case report: A 35-year-old Brazilian female with
homozygous SCA was admitted for a program of partial
exchange transfusion prior to cholecystectomy. Her blood
group was O RhD positive and no atypical RBC alloantibody
was detected using the indirect antiglobulin technique. Pre-
transfusional hemoglobin (Hb) was 8.7 g/dL and isovolumic
partial exchange transfusion was performed using 4 units of
ABO compatible packed RBC. Five days after the last
transfusion she developed generalized joint pain and fever
of 39°C. Her Hb level dropped from 12.0 g/dL to 9.3 g/dL
and the unconjugated bilirrubin level rose to 27 mmol/L. She
was jaundiced and had hemoglobinuria. Hemoglobin
electrophoresis showed 48.7% HbS, 46.6% HbA1, 2.7%
HbA2, and 2.0% HbF. The patient’s extended RBC
phenotype was CDe, K-k+, Kp(a-b+), Fy(a-b-), M+N+s+,
Le(a+b-), Di(a-). An RBC alloantibody with specificity to the
Rh system (anti-c, titer 1:16.384) was identified by the
indirect antiglobulin test. The Rh phenotype of the RBC used
in the last packed RBC transfusion was CcDEe. The patient
was discharged, asymptomatic, 7 days after admission.
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CASE REPORT
A 35-year-old Brazilian female with
homozygous SCA was admitted for a program of
partial exchange transfusion prior to
cholecystectomy. Her blood group was O RhD
positive and no atypical RBC alloantibody was
detected using the indirect antiglobulin technique.
Pre-transfusional hemoglobin (Hb) was 8.7 g/dL
and isovolumic partial exchange transfusion was
performed using 4 units of ABO compatible packed
RBC. Figure 1 shows the serial Hb levels in relation
to the blood transfusion program.  Five days after
the last transfusion she developed generalized joint
pain and fever of 39°C. Her Hb level dropped
from 12.0 g/dL to 9.3 g/dL and the unconjugated
bilirrubin level rose to 27 mmol/L. She was
jaundiced and had hemoglobinuria. Hemoglobin
electrophoresis showed 48.7% HbS, 46.6% HbA1,
2.7% HbA2, and 2.0% HbF.
The patient’s extended RBC phenotype was
CDe, K-k+, Kp(a-b+), Fy(a-b-), M+N+s+, Le(a+b),
Di(a-). An RBC alloantibody with specificity to the
Rh system (anti-c, titer 1:16.384) was identified
by the indirect antiglobulin test. The Rh phenotype
of the RBC used in the last packed RBC transfusion
was CcDEe. The patient was discharged,
asymptomatic, 7 days after admission.
DISCUSSION
It has been reported that the prevalence of DHTR
in patients with SCA ranges from 0.7 to 4%.
2,3
Moreover, there are few published reports of cases
in which the development of DTHR presents as a
painful crisis.
2,4
 Although the RBC alloimmunization
rate among multitransfused Brazilian patients with
SCA is lower than previously reported rates in the
United States,
1,2
 the present case illustrates that DHTR
occurs and can easily be mistaken for a painful sickle
cell crisis, even in countries with low antigen
mismatching between blood donors and SCA
recipients. Interestingly, in contrast to the fact that about
40% of the potentially hemolytic RBC alloantibodies
are usually not detected even after long-term follow-
up, the presence of the above-mentioned RBC
alloantibody (anti-c, titer 1:16) is still demonstrable in
our patient’s serum 5 years after her last blood
transfusion. In conclusion, this case reveals some of
the problems associated with the prevention and
diagnosis of DHTR in patients with SCA transfused in
countries where the rates of phenotypic incompatibility
between donors and recipients are low.
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RESUMO
Contexto: Pacientes com anemia falciforme recebem com freqüência concentrados de glóbulos vermelhos (CGV).
Recentemente, nós relatamos que o risco de alo-imunização eritrocitária por unidade transfundida em pacientes brasileiros
com anemia falciforme é 1,15%. Relato de caso: Nós descrevemos uma reação transfusional hemolítica tardia (RTHT)
apresentando-se como uma crise dolorosa em um paciente com anemia falciforme.
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